focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Leiwounion thanks for your post.
To confirm how it’s administered in the REMAP-CAP trial
Interferon ß1a - 10 µg will be diluted in 1 mL of sterile water. The diluted IFN-ß1a will be administered as an intravenous bolus injection via a central or peripheral line. The injection will be followed with a 5 mL flush of sterile saline. IFN-ß1a will be administered once daily for 6 days or until ICU discharge, whichever occurs first.
The pressure on the Finnish medical body to introduce traumakine to severely ill patients will surely increase after the petition is handed in today with thousands of signatures on it. Does our Finnish fellow investor have any more updates on this?
You would have to assume that with the seriousness of this virus and the economic impact being felt globally with the threat of a global recession imminent that the FDA and WHO are looking at drugs not currently available to the market that are known to work proven by trials to be fast tracked as a matter of urgency. There are clearly not enough ventilators available now let alone in 2 weeks time so there is no better time to unleash Traumakine to help the people suffering with respiratory problems caused by covid-19.
Itsall and co, what a great day, couldn’t believe it was up at 370 at one point when I looked after coming from a meeting. What do you think drove that rise? A Corona virus dominated news day? A leak of good news? Surely not P&D? Hoping for the same tomorrow!
He’s back! Are those your trades GB, 6 shares twice an 11 and 12?
The proactive investor interview was very encouraging, definitely a twinkle in Markku’s eye, and the presentation yesterday was fantastic, loving the new project thought.
CB you’re right, things just get better and better with this investment.